Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1999
08/19/1999WO1999041396A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999WO1999041269A1 Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
08/19/1999WO1999041268A1 Nucleosides
08/19/1999WO1999041267A1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
08/19/1999WO1999041265A1 Novel substances kf-1040 and process for producing the same
08/19/1999WO1999041262A1 Telomerase inhibitors
08/19/1999WO1999041258A1 Novel dimerizing agents, their production and use
08/19/1999WO1999041257A1 Glucocorticoid-selective antiinflammatory agents
08/19/1999WO1999041254A1 NOVEL TRIAZOLO(4,5-d)PYRIMIDINE COMPOUNDS
08/19/1999WO1999041253A1 Anti-viral pyrimidine derivatives
08/19/1999WO1999041252A1 Antagonists of gonadotropin releasing hormone
08/19/1999WO1999041251A1 Antagonists of gonadotropin releasing hormone
08/19/1999WO1999041248A1 Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
08/19/1999WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999WO1999041244A1 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
08/19/1999WO1999041241A1 Heterocyclic topoisomerase poisons
08/19/1999WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
08/19/1999WO1999041237A1 Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
08/19/1999WO1999041235A1 Farnesyl transferase inhibitors
08/19/1999WO1999041232A1 Cytostatic agents
08/19/1999WO1999041230A1 Processes and intermediates useful to make antifolates
08/19/1999WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999WO1999041220A1 Stable hyperforin salts, method for producing same and their use in the treatment of alzheimer's disease
08/19/1999WO1999040955A2 Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
08/19/1999WO1999040946A2 Methods and compositions for modulating leptin activity
08/19/1999WO1999040944A2 Hydroxylation activated drug release
08/19/1999WO1999040943A1 Solubilizing delivery systems and method of manufacture
08/19/1999WO1999040931A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
08/19/1999WO1999040926A1 Agents and methods for protection, treatment and repair of connective tissue
08/19/1999WO1999040923A1 Preventive and therapeutic agent for fatty liver
08/19/1999WO1999040922A1 Composition for reducing serum cholesterol levels
08/19/1999WO1999040921A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
08/19/1999WO1999040920A1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
08/19/1999WO1999040919A1 Remedies for cardiac dilastolic disorders
08/19/1999WO1999040918A1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations
08/19/1999WO1999040917A1 Combination of an alpha-adrenergic antagonist and a nitrogen oxide donor for treating female sexual dysfunction
08/19/1999WO1999040916A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
08/19/1999WO1999040915A1 Method of treating migraine
08/19/1999WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999WO1999040913A1 Chemical compounds
08/19/1999WO1999040912A1 Method of stimulating apoptosis using trichothecene mycotoxins
08/19/1999WO1999040911A1 Use of selenium compounds for preventing and treating alzheimer disease
08/19/1999WO1999040910A1 Anti-inflammatory agents
08/19/1999WO1999040909A1 Method for modulating macrophage activation
08/19/1999WO1999040908A1 Use of deprenyl compounds to treat viral infections and reduce tissue damage associated therewith
08/19/1999WO1999040907A1 Methods for the controlled delivery of carbon disulfide for the treatment of inflammatory conditions
08/19/1999WO1999040906A2 Method and composition for treatment of inflammatory conditions
08/19/1999WO1999040905A2 Use of hyperforin and hyperforin-containing extracts in the treatment and prophylaxis of dementing diseases
08/19/1999WO1999040904A2 Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia
08/19/1999WO1999040900A1 Droperidol compositions and method for using same
08/19/1999WO1999040888A1 Compositions and methods of treating keratin-related disorders and conditions
08/19/1999WO1999040883A2 Compositions and methods for the treatment of cystic fibrosis
08/19/1999WO1999040867A1 Treatment of brain edema using carbonic anhydrase enzyme inhibitor
08/19/1999WO1999040789A1 Methods and compounds for the genetic treatment of hyperlipidemia
08/19/1999WO1999040788A1 Inotropic and diuretic effects of exendin and glp-1
08/19/1999WO1999032098A3 Combination of a ramba and a tocopherol
08/19/1999WO1999031141A3 Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof
08/19/1999WO1999030719A3 Use of an oestrogen for treating postnatal depression
08/19/1999WO1999030708A3 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents
08/19/1999WO1999030694A3 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
08/19/1999WO1999029662A3 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
08/19/1999WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof
08/19/1999WO1999025354A3 Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters
08/19/1999WO1999024451A3 Adenosine a1 receptor agonists
08/19/1999WO1999024450A3 Adensine a1 receptor agonists
08/19/1999WO1999024449A3 Adenosine a1 receptor agonists
08/19/1999WO1999024448A3 New sophoroselipids, method for their production and use
08/19/1999WO1999024394A3 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
08/19/1999WO1999024024A3 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
08/19/1999WO1999023996A3 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor
08/19/1999WO1999023227A3 Hyaluronan synthase gene and uses thereof
08/19/1999WO1999023108A9 Inducible phosphofructokinase and the warburg effect
08/19/1999WO1999021845A3 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
08/19/1999WO1999021551A9 Matrix for controlled delivery of highly soluble drugs
08/19/1999WO1999016412A3 Non-irritating cosmetic and pharmaceutical compositions
08/19/1999WO1999015894A3 Method of identification of leads or active compounds
08/19/1999WO1999012570A3 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
08/19/1999WO1999001416A3 1-amino-alkylcyclohexane nmda receptor antagonists
08/19/1999WO1998055110A3 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION
08/19/1999WO1998052514A3 Treatment of hepatic cirrhosis
08/19/1999WO1998050074A3 Compositions of antichlamydial agents for the diagnosis and management of infection caused by chlamydia
08/19/1999WO1998020095A3 Washing disinfectant for hygienic and surgical hand disinfection
08/19/1999WO1998008966A8 Loxoprofen-containing preparation for external use
08/19/1999WO1997003655A8 Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
08/19/1999DE19806438A1 New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer
08/19/1999DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments
08/19/1999CA2632106A1 Method for modulating macrophage activation
08/19/1999CA2324426A1 Compositions and methods for the treatment of cystic fibrosis
08/19/1999CA2321750A1 Composition for reducing serum cholesterol levels
08/19/1999CA2321220A1 Use of negative regulation elements for nerve-specific expression of transgenes
08/19/1999CA2321218A1 Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
08/19/1999CA2321153A1 Anti-viral pyrimidine derivatives
08/19/1999CA2320992A1 Use of deprenyl compounds to treat viral infections and reduce tissue damage associated therewith
08/19/1999CA2320965A1 Methods and compounds for the genetic treatment of hyperlipidemia
08/19/1999CA2320934A1 Treatment of brain edema using carbonic anhydrase inhibitor
08/19/1999CA2320911A1 Glucocorticoid-selective anti-inflammatory agents
08/19/1999CA2320381A1 Cytostatic agents
08/19/1999CA2320378A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders
08/19/1999CA2320285A1 Anti-inflammatory agents
08/19/1999CA2320226A1 Methods and compositions for modulating leptin activity
1 ... 6457 6458 6459 6460 6461 6462 6463 6464 6465 6466 6467 6468 6469 6470 6471 6472 6473 6474 6475 6476 6477 ... 7860